CVE-2017-17678

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting XSS. A DOM-based cross-site scripting vulnerability was discovered in a legacy utility...

CVE-2017-17678

Affected product: BMC Remedy Mid Tier 9.1SP3. Vulnerability: DOM-based cross-site scripting (XSS) in a legacy utility within the web interface. Root cause: likely improper handling of user-controllable input in the legacy utility, enabling script execution in the browser context. Impact: cross-si...